Molecular phenotype of CXCL12β 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression

Current HIV Research

Volumn 7, Issue 4, 2009, Pages 384-389

  Garcia Moruja, Carelia ^a   Rueda, Patricia ^a   Torres, Carmen ^a   Alcamí, José ^b   Luque, Francisco ^a   Caruz, Antonio ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

AIDS; CXCL12; mRNA stability; rs1801157; UTR

Indexed keywords

ADENINE; GUANINE; IONOMYCIN; LUCIFERASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; EMBRYO; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LUNG FIBROBLAST; MOLECULAR CLONING; PHENOTYPE; PLASMID; PROMOTER REGION; RNA STABILITY; CELL LINE; GENE FUSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; METABOLISM; POINT MUTATION; REPORTER GENE;

3' UNTRANSLATED REGIONS; ARTIFICIAL GENE FUSION; CELL LINE; CHEMOKINE CXCL12; CLONING, MOLECULAR; GENES, REPORTER; HIV; HUMANS; IMMUNITY, INNATE; LUCIFERASES; PLASMIDS; POINT MUTATION; POLYMORPHISM, GENETIC; RNA STABILITY; TRANSFECTION;

EID: 69849107435     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788680543     Document Type: Article

References (57)

1. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993; 261: 600-603 (Pubitemid 23278369)
2. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-833 (Pubitemid 26299570)
3. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595-599 (Pubitemid 28319251)
4. Ma Q, Jones D, Borghesani PR, et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448-9453 (Pubitemid 28506251)
5. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-638 (Pubitemid 26268957)
6. Ara T, Nakamura Y, Egawa T, et al. Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc Natl Acad Sci USA 2003; 100: 5319-5323 (Pubitemid 36542703)
7. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997; 185: 111-120 (Pubitemid 27039446)
8. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998; 279: 381-384 (Pubitemid 28063373)
9. Grabovsky V, Feigelson S, Chen C, et al. Subsecond induction of alpha 4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 2000; 192: 495-506. (Pubitemid 30666250)
10. Yu L, Cecil J, Peng SB, et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006; 374: 174-179 (Pubitemid 43750309)
11. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-877
12. Hori T, Sakaida H, Sato A, et al. Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic HIV-1 by three different monoclonal antibodies. J Immunol 1998; 160: 180-188 (Pubitemid 28116728)
13. Stephens HA. HIV-1 diversity versus HLA class I polymorphism. Trends Immunol 2005; 26: 41-47
14. An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002; 99: 10002-10007
15. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307: 1434-1440 (Pubitemid 40321934)
16. Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581-4585 (Pubitemid 29190379)
17. McDermott DH, Beecroft MJ, Kleeberger CA, et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000; 14: 2671-2678
18. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005; 191 (Suppl 1): 68-77. (Pubitemid 40144231)
19. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393 (Pubitemid 28063375)
20. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001; 135: 782-795
21. Dubois-Laforgue D, Hendel H, Caillat-Zucman S, et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 2001; 50: 1211-1213 (Pubitemid 32374556)
22. Joven B, Gonzalez N, Aguilar F, et al. Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis. Arthritis Rheum 2005; 52: 354-356 (Pubitemid 40129269)
23. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 2005; 225: 261-266 (Pubitemid 40835873)
24. Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 2005; 49: 311-315 (Pubitemid 41139143)
25. Dimberg J, Hugander A, Lofgren S, Wagsater D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med 2007; 19: 11-15
26. Garcia-Moruja C, Alonso-Lobo JM, Rueda P, et al. Functional characterization of SDF-1 proximal promoter. J Mol Biol 2005; 348: 43-62. (Pubitemid 40461839)
27. Zhao J, Hyman L, Moore C. Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999; 63: 405-445 (Pubitemid 29264977)
28. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL. eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR. J Cell Biol 2005; 169: 245-256
29. Zehner ZE, Shepherd RK, Gabryszuk J, Fu TF, Al-Ali M, Holmes WM. RNA-protein interactions within the 3 ' untranslated region of vimentin mRNA. Nucleic Acids Res 1997; 25: 3362-3370 (Pubitemid 27338699)
30. Al-Maghrebi M, Brule H, Padkina M, Allen C, Holmes WM, Zehner ZE. The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1. Nucleic Acids Res 2002; 30: 5017-5028 (Pubitemid 36033019)
31. Adereth Y, Dammai V, Kose N, Li R, Hsu T. RNA-dependent integrin alpha3 protein localization regulated by the Muscleblindlike protein MLP1. Nat Cell Biol 2005; 7: 1240-1247 (Pubitemid 41741737)
32. Stoeckle MY. Removal of a 3' non-coding sequence is an initial step in degradation of gro alpha mRNA and is regulated by interleukin-1. Nucleic Acids Res 1992; 20: 1123-1127
33. Espel E. The role of the AU-rich elements of mRNAs in controlling translation. Semin Cell Dev Biol 2005; 16: 59-67. (Pubitemid 40136538)
34. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. Identification of a common nucleotide sequence in the 3'- untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986; 83: 1670-1674 (Pubitemid 16018626)
35. Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659-667
36. Weiss IM, Liebhaber SA. Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol 1995; 15: 2457-2465
37. Christian K, Lang M, Maurel P, Raffalli-Mathieu F. Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA: implications for post-transcriptional regulation of the CYP2A6 gene. Mol Pharmacol 2004; 65: 1405-1414 (Pubitemid 38668299)
38. Jaeger S, Barends S, Giege R, Eriani G, Martin F. Expression of metazoan replication-dependent histone genes. Biochimie 2005; 87: 827-834 (Pubitemid 41297809)
39. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524 (Pubitemid 43345317)
40. Jankovic L, Dimovski AJ, Kollia P, Karageorga M, Loukopoulos D, Huisman TH. A C-G mutation at nt position 6 3' to the terminating codon may be the cause of a silent beta-thalassemia. Int J Hematol 1991; 54: 289-293
41. Maragoudaki E, Vrettou C, Kanavakis E, Traeger-Synodinos J, Metaxotou-Mavrommati A, Kattamis C. Molecular, haematological and clinical studies of a silent beta-gene C>G mutation at 6 bp 3' to the termination codon (+1480 C-->G) in twelve Greek families. Br J Haematol 1998; 103: 45-51. (Pubitemid 28470798)
42. Sgourou A, Papachatzopoulou A, Psiouri L, et al. The beta-globin C>G mutation at 6 bp 3' to the termination codon causes betathalassaemia by decreasing the mRNA level. Br J Haematol 2002; 118: 671-676 (Pubitemid 34994680)
43. Basak AN, Ozer A, Kirdar B, Akar N. A novel 13 Bp deletion in the 3'UTR of the beta-globin gene causes beta-thalassemia in a Turkish patient. Hemoglobin 1993; 17: 551-555 (Pubitemid 24006299)
44. Bilenoglu O, Basak AN, Russell JE. A 3'UTR mutation affects beta-globin expression without altering the stability of its fully processed mRNA. Br J Haematol 2002; 119: 1106-1114 (Pubitemid 35463840)
45. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005; 310: 317-320
46. Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 2006; 17: 823-830
47. Han SW, Kim GW, Seo JS, et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 2004; 43: 1173-1177 (Pubitemid 39232824)
48. Krippl P, Langsenlehner U, Renner W, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 2003; 106: 468-471 (Pubitemid 36966201)
49. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003; 123: 1520-1526 (Pubitemid 36549771)
50. Rabkin CS, Yang Q, Goedert JJ, Nguyen G, Mitsuya H, Sei S. Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 1999; 93: 1838-1842 (Pubitemid 29128484)
51. Coll B, Alonso-Villaverde C, Parra S, et al. The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients. AIDS 2005; 19: 1877-1883.
52. Dommange F, Cartron G, Espanel C, et al. CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia. FASEB J 2006; 20: 1913-1915 (Pubitemid 44933777)
53. Ramamoorti N, Kumarvelu J, Shanmugasundaram GK, Rani K, Banerjea AC. High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 3'-untranslated region of SDF-1 RNA. Genes Immun 2001; 2: 408-410
54. Modi WS, Scott K, Goedert JJ, et al. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. Genes Immun 2005; 6: 691-698 (Pubitemid 41741714)
55. Rueda P, Balabanian K, Lagane B, et al. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS ONE 2008; 3: e2543.
56. Segret A, Rucker-Martin C, Pavoine C, et al. Structural Localization and Expression of CXCL12 and CXCR4 in Rat Heart and Isolated Cardiac Myocytes. J Histochem Cytochem 2007; 55: 141-155 (Pubitemid 46147691)
57. Stumm RK, Rummel J, Junker V, et al. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoformselective regulation of SDF-1 expression modulates CXCR4- dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 2002; 22: 5865-5878 (Pubitemid 35387631)